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Plasmodium falciparum
PSACErythrocytes infected with malaria parasites have increased permeability to various solutes. These changes
may be mediated by an unusual small conductance ion channel known as the plasmodial surface anion
channel (PSAC). While channel activity beneﬁts the parasite by permitting nutrient acquisition, it can also be
detrimental because water-soluble antimalarials may more readily access their parasite targets via this
channel. Recently, two such toxins, blasticidin S and leupeptin, were used to select mutant parasites with
altered PSAC activities, suggesting acquired resistance via reduced channel-mediated toxin uptake.
Surprisingly, although these toxins have similar structures and charge, we now show that reduced
permeability of one does not protect the intracellular parasite from the other. Leupeptin accumulation in the
blasticidin S-resistant mutant was relatively preserved, consistent with retained in vitro susceptibility to
leupeptin. Subsequent in vitro selection with both toxins generated a double mutant parasite having
additional changes in PSAC, implicating an antimalarial resistance mechanism for water-soluble drugs
requiring channel-mediated uptake at the erythrocyte membrane. Characterization of these mutants
revealed a single conserved channel on each mutant, albeit with distinct gating properties. These ﬁndings are
consistent with a shared channel that mediates uptake of ions, nutrients and toxins. This channel's gating
and selectivity properties can be modiﬁed in response to in vitro selective pressure.Vector Research, NIAID/NIH,
20852-8132, USA. Tel.: +1 301
B.V.Published by Elsevier B.V.1. Introduction
Invasion and growth within erythrocytes is a hallmark of
plasmodium species; it permits these parasites to evade host immune
responses and provides access to hemoglobin as a nutritive source. In
the case of Plasmodium falciparum, the cause of the most severe form
of human malaria, growth within erythrocytes also accounts for most
of the clinical sequelae. Intracellular growth is associated with a
dramatic remodeling of the host cytosol, with export of a large
number of proteins to this compartment [1,2], generation of a
specialized membranous network [3], and changes in erythrocyte
membrane properties including increased permeability to various
organic and inorganic solutes [4–6].
Electrophysiological studies have now established that the
permeability changes result from one or more deﬁned ion channels
and cannot be attributed to non-speciﬁc membrane leaks [7]. While
several other ion channels have been reported, a number of studiesnow point to the plasmodial surface anion channel (PSAC) as the
primary uptake mechanism for most, if not all, small uncharged
solutes and monovalent ions [8–10]. PSAC activity is conserved on
erythrocytes infected with other malaria parasites [11] and is absent
on cells infected with Babesia divergens, another apicomplexan
parasite that invades human erythrocytes [12]. PSAC also has a
number of unusual functional properties that distinguish it from
known ion channels in higher organisms [13–15].
In vitro selection has recently been used to generate two separate
parasite mutants that carry altered PSAC activity [9,16]. One mutant
was generated after selection with blasticidin S, a peptidyl nucleoside
antibiotic presumed to kill parasites by inhibiting protein translation
on ribosomes within the intracellular parasite [17]. Although
blasticidin S has been used in basic malaria research to select for
transfected parasites expressing the deaminase BSD [18–20], a
resistant mutant was spontaneously selected by continuous applica-
tion of blasticidin S pressure to a speciﬁc parasite isolate (FCB) in the
absence of the BSD resistance gene. The second channel mutant was
selected with leupeptin, a cysteine and serine protease inhibitor that
has multiple intracellular parasite targets [21–23]. This mutant did
not havemeasurable changes in cellular protease activity or leupeptin
sensitivity of parasite proteases; there were also no detectable
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What is the mechanism of acquired resistance in these two
mutants? Because biochemical characterization revealed altered PSAC
activity, both studies proposed that in vitro resistance results from
changes in the channel that reduce toxin uptake at the host
erythrocyte membrane and thereby prevent access to intracellular
targets. However, parasite survival and expansion under selective
pressure are complex and there are alternative explanations that
deserve examination. Moreover, a number of other ion channels have
been proposed for the infected erythrocyte membrane [7], further
complicating interpretation of the macroscopic measurements in the
previous reports.
To address these concerns, we have now undertaken more
rigorous characterization of these mutants. First, we determined
that resistance to either leupeptin or blasticidin S confers minimal
protection against the other agent. We then used in vitro selection to
generate a new parasite mutant resistant to both blasticidin S and
leupeptin. Cell-attached patch-clamp revealed distinct changes in
single channel gating and conductance that were strictly associated
with each of the three mutant phenotypes, supporting the proposal of
resistance acquired by selection of changes in a single ion channel
type. Our study also provides insights into the PSAC's selectivity ﬁlter,
which appears to have a surprising ability to allow permeation of a
broad range of charged and uncharged solutes while maintaining the
ability to distinguish between solutes of similar size, geometry, and
charge.
2. Materials and methods
2.1. Growth inhibition assays
Isobologram analysis of growth inhibition by combinations of
compound 2 with blasticidin S or leupeptin were performed using a
SYBR green I-based ﬂuorescence assay for parasite nucleic acid in 96-
well format. Wild-type parasite cultures were synchronized in 5% D-
sorbitol before seeding at 0.2 to 0.5% parasitemia and 5% hematocrit in
RPMI 1640 supplemented with 25 mM HEPES, 2% serum, 50 mg/liter
hypoxanthine, and deﬁned dilutions of PSAC antagonist with toxin.
Cultures were maintained for 3 days at 37 °C in 5% O2–5% CO2. The
plates were then subjected to freezing–thawing before addition of
SYBR green I at twice the manufacturer's recommended ﬁnal
concentration, incubation for 30 min, and measurement of ﬂuores-
cence (excitation and emission wavelengths of 485 and 528 nm,
respectively). Background ﬂuorescence was subtracted by use of
control cultures killed by 20 µM chloroquine. IC50 values for each ratio
of PSAC antagonist and toxin were estimated by linear interpolation.
Similar results were obtained with the Indo 1 and HB3 laboratory
parasite lines.
2.2. In vitro selection of FCB-2mut
Mutant parasite lines resistant to blasticidin S or leupeptin were
selected by continuous cultivation of wild-type parasites as described
previously [9,16]. To select for a parasite resistant to both toxins,
we challenged the single mutant lines FCB-br1 and HB3-leuR1 with
2.5 µg/mL blasticidin S and 50 µM leupeptin. After extended contin-
uous cultivation (∼6 months), a double mutant was generated from
FCB-br1 on both of two separate attempts. The clone, FCB-2mut, was
then obtained by limiting-dilution cloning. We were unsuccessful in
attempts to generate a double mutant from the HB3-leuR1 line.
2.3. Leupeptin accumulation by intact cells
Leupeptin accumulation into erythrocytes infected with various
parasite isolates were performed with a semi-quantitative assay thatmeasures papain-mediated hydrolysis of Z-Phe-Arg-AMC and its
inhibition by leupeptin from cell lysates [16]. We measured leupeptin
content of intact cells after a 30 min preincubation with 40 µM
leupeptin in PBS. This leupeptin concentration and preincubation
duration optimally distinguishes between uptake by infected and
uninfected cells, permitting sensitive detection of PSAC-mediated
uptake. Measurement of uptake entailed rapid washes to reduce
extracellular leupeptin to undetectable levels, lysis of the infected cell
membrane with 0.05% saponin, addition of the released erythrocyte
cytosolic contents to a buffered papain and Z-Phe-Arg-AMC mixture,
and detection of ﬂuorescence. Z-Phe-Arg-AMC is a peptide substrate
that exhibits a marked ﬂuorescence increase when digested by
papain, a leupeptin-sensitive protease. Fluorescence measurements
were normalized to % leupeptin content by comparison to matched
controls incubated without leupeptin, which was deﬁned as 0%
content; complete inhibition of papain-mediated hydrolysis was set
to 100% content. Control wild-type parasites were included in each
experiment that examined parasite mutants, allowing direct compar-
ison of accumulation.
2.4. Osmotic lysis kinetics
Continuous tracking of infected erythrocyte osmotic lysis kinetics
in organic solutes was used to examine PSAC activity and was
performed as described previously [24]. Trophozoite-infected ery-
throcytes were enriched by percoll-sorbitol separation, washed in PBS
(150 mM NaCl, 20 mM Na2HPO4, pH 7.5), and resuspended at 37 oC
and 0.15% hematocrit in permeant solutes (145 mM PhTMA+ chloride
or 280 mM sorbitol) buffered with 20 mM Na-HEPES, 0.1 mg/ml BSA,
pH 7.4. Osmotic swelling and lysis were then continuously monitored
by recording transmittance of 700 nm light through the cell
suspension (DU640 spectrophotometer with Peltier temperature
control, Beckman Coulter). The resulting transmittance recordings
were normalized so that 100% osmotic lysis of infected cells
corresponds to the steady-state transmittance measured after
extended incubation (typically 2 h). The time to 50% lysis was
estimated by interpolation. The dose–response for inhibition by
compound 2 was determined using osmotic lysis experiments with
sorbitol, as described [24].
2.5. Electrophysiology
Cell-attached patch-clamp recordings of trophozoite-stage
infected erythrocytes were obtained as described previously [8]. All
recordings used symmetric bath and pipette solutions of 1000 mM
choline chloride, 115 mM NaCl, 10 mM MgCl2, 5 mM CaCl2, 20 mM
Na-HEPES, pH 7.4. This hypertonic solution increases the signal-to-
noise ratio for single PSAC detection by increasing Cl− ﬂux through
open channels and by reducing pipette electrical noise. Pipettes were
fabricated from quartz capillaries and had resistances of 1 to 3 MΩ in
the recording solution. Seal resistances were greater than 100 GΩ.
Holding membrane potential was 0 mV; all recordings shown were
obtained with pulses to −100 mV. We did not use perfusion of the
bath. Voltage clamp recordings were obtained with an Axopatch 200B
ampliﬁer (Molecular Devices), ﬁltered at 5 kHz, digitized at 100 kHz,
and recorded with Clampex 9.0 software (Molecular Devices).
Dwell time distributions were determined from up to 75 s of single
channel recordings for each isolate by using home-written code that
detects mid-threshold crossings, uses linear interpolation of adjacent
sample times, and corrects for a Gaussian ﬁlter risetime of 66.4 μs as
described in detail previously [14]. Histogram ordinate values were
normalized to percent of the total number of events detected under
each condition. Histograms are displayed on square root-logarithmic
plots because time constants for simple exponentially decaying
processes are visible as maxima [25]. Spectral analyses were carried
out as described previously [6,26]. These analyses used continuous
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membrane potential of −100 mV with minimal ﬁltering (30 kHz
Butterworth).
3. Results
3.1. Similar structures and resistance mechanisms for blasticidin S and
leupeptin
Both blasticidin S and leupeptin carry a positively charged
guanidinium moiety and have relatively high molecular weights
(N420 Da; Fig. 1A), two features that limit membrane permeability
and, hence, toxicity against many cell types [27–30]. Both agents
nevertheless kill in vitro cultures of P. falciparum and are thought to
work against intraerythrocytic targets [17,31]. How these toxins enter
infected cells is therefore an important question and is not well-
established. One possibility is that they enter infected erythrocytes via
the plasmodial surface anion channel (PSAC), a broad permeability
ion channel not present on uninfected cells [6]. Consistent with this
possibility, both blasticidin S- and leupeptin-resistant malaria para-
sites exhibit marked changes in PSAC activity, suggesting acquisition
of resistance primarily due to changes in this channel that yield
reduced uptake of toxin [9,16].
We began with an independent test of this possibility by
examining growth inhibition by blasticidin S or leupeptin in the
presence of a recently identiﬁed high afﬁnity PSAC antagonist
(compound 2, Fig. 1B–D; [32]). Because this and other PSAC
antagonists also kill parasites [33], we performed dose responses of
combinations of each toxin with compound 2 and quantiﬁed parasite
killing using SYBR Green I-based detection of parasite DNA. The
relative killing by toxin and channel antagonist in each mixture was
determined through isobologram analyses as shown in Fig. 1E. In
these graphs, the IC50 values for these combinations were signiﬁcantly
shifted to the right of the line of additive effect (solid diagonal),
expected for non-interacting combinations. Moreover, the direction of
these shifts indicates that blasticidin S and leupeptin toxicities are
reduced by the PSAC antagonist. While similar antagonism of
leupeptin toxicity has been reported with NPF-1, a known PSAC
antagonist [16], it has not been previously demonstrated for
blasticidin S. Similar antagonism by two unrelated PSAC inhibitors is
strong evidence against the alternate hypothesis that NPF-1 and 2
interfere with leupeptin or blasticidin S toxicity via a mechanism
other than inhibited uptake at the erythrocyte membrane. These
observations suggest PSAC-mediated uptake of blasticidin S and
leupeptin is an essential step in their toxic effects.
3.2. Limited cross-resistance and generation of a double mutant
In light of the similar structures of these toxins and the apparent
similarities in their acquired resistance mechanisms, we next
wondered whether these parasite mutants exhibit cross-resistance.
The blasticidin S-resistant parasite clone could only be generated from
the FCB laboratory isolate and is therefore called FCB-br1; the
leupeptin-resistant isolate could only be generated from the HB3
wild-type isolate and is here referred to as HB3-leuR1. In light of the
requirement of speciﬁc parasite genetic backgrounds, we examined
growth rates of both wild-type parents and each mutant. In the
absence of either toxin, each of these parasites grew well with
increasing parasitemia every 48 h, the duration of the intraerythro-
cytic cycle (Fig. 2A). As reported previously [9], the blasticidin S-
resistant parasite, FCB-br1, exhibited smaller increases in parasitemia
with each cycle. Addition of either 50 µM leupeptin or 2.5 µM
blasticidin S rapidly sterilized cultures of both wild-type parents,
but allowed expansion of the corresponding mutant (Fig. 2B and C,
respectively). Importantly, these experiments revealed minimal
cross-resistance because each single mutant was quickly killed bythe other toxin. Simultaneous application of both blasticidin S and
leupeptin cleared cultures of either mutant (Fig. 2D).
We next used in vitro selection to generate a parasite mutant
resistant to both blasticidin S and leupeptin because it may carry
additional distinct changes in PSAC. This parasite, referred to here as
FCB-2mut, shares the slow growth of the FCB-br1 single mutant in the
absence of drug pressure and can be propagated in the presence of
either or both toxins (red symbols, Fig. 2). We also attempted to
create a double mutant by challenging the leupeptin-resistant HB3-
leuR1 isolate with 2.5 µg/mL blasticidin S, but were unable on three
separate selections. Wild-type FCB parasites were also challenged
with 50 µM leupeptin alone, but these selections failed to generate
leupeptin resistance (n=3 attempts), suggesting that changes in the
channel acquired during selection with blasticidin S resistance are
permissive for generation of leupeptin resistance. Similarly, we have
not been able to generate blasticidin S resistance by in vitro selections
using the HB3 isolate (n=4). These ﬁndings, summarized in Fig. 3,
suggest a requirement for a certain genetic background in the
generation of each mutant. The wild-type isolates used here
presumably carry polymorphisms in one or more parasite genes
that are permissive for accrual of resistance mutations.
3.3. Reduced leupeptin permeability in the double mutant
We next used a semi-quantitative permeability assay to measure
leupeptin uptake by erythrocytes before and after infection with each
of these parasite isolates to examine possible mechanisms of
resistance (Fig. 4). Uninfected erythrocytes exhibited low leupeptin
uptake in this assay [16]. Erythrocytes infected with either of the two
wild-type parasite isolates, FCB and HB3, exhibited high leupeptin
permeability that was attributed to PSAC because it could be largely
abolished by compound 2, the speciﬁc PSAC inhibitor used in Fig. 1.
Leupeptin permeability was also affected by selection of blasticidin S-
or leupeptin-resistant mutants. Selection with blasticidin S yielded
only a modest reduction in leupeptin permeability (FCB-br1 isolate).
This intermediate value may produce limited cross-resistance
between blasticidin S and leupeptin, but is not sufﬁcient to permit
continuous propagation of FCB-br1 cultures in the presence of 50 µM
leupeptin. Selection of the double mutant from the FCB-br1 back-
ground reduced leupeptin permeability further, reaching a level
similar to that in the HB3-leuR1 single mutant. These ﬁndings are
consistent with a threshold level of leupeptin uptake required for
parasite killing in vitro. They also suggest that the double mutant
isolate may be resistant to leupeptin because of additional changes in
this ion channel.
3.4. Distinct PSAC single channel properties for each mutant
To examine this and other possibilities, we performed cell-
attached patch-clamp of erythrocytes infected with each parasite
and obtained single channel recordings. With each isolate, only a
single ion channel type was detected under our recording conditions.
Inspection of these recordings reveals that while some single channel
properties are similar among these ﬁve isolates, there are also
important differences. Most obviously, the frequency and timing of
transitions between open and closed states, commonly referred to as
“gating”, differ markedly between isolates (Fig. 5). These differences
were reproducible in recordings from multiple separate cells as
demonstrated with individual traces from 3 separate cells for each
parasite in Fig. 5B.
As described previously [9], recordings on erythrocytes infected
with the FCB-br1 isolate revealed frequent transitions to an interme-
diate conductance level. Interestingly, in vitro selection of the double
mutant from the FCB-br1 background abolished this subconductance
state and reestablished relatively simpler transitions between the
open and closed states (FCB-2mut traces). As apparent from the
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double mutant exhibits a modest, but statistically signiﬁcant
increased single channel conductance (Fig. 6, P=10−5, Student's t
test).
To allay concerns about biased selection of traces, we analyzed the
durations of open and closed channel events, known as dwell times,Fig. 1. Toxicity of blasticidin S and leupeptin is reduced by a speciﬁc PSAC antagonist. (A) S
positively charged, bulky organic solutes that cross membranes poorly. (B) Structure of comp
response for inhibition of sorbitol-mediated osmotic lysis by compound 2. Solid line represen
obtained without (top trace) or with 500 nM compound 2 (remaining traces) in both bath an
the traces represent 1 s (horizontal) and 2 pA (vertical). (E) Isobolograms for parasite grow
panels, respectively). Each symbol represents concentrations of toxin and compound 2 that p
independent experiments. The solid line represents the line of additivity, expected for non-in
each panel, indicating that compound 2 antagonizes killing by both toxins.from extended single channel recordings on themutant andwild-type
infected cells. Fig. 7A shows the resulting all points histograms
generated from individual channel molecules from FCB and FCB-2mut;
Fig. 7B displays the results for HB3 and HB3-leuR1.
For each isolate, the distributions of open durations revealed a
single unambiguous peak (left panels in Fig. 7A and B). The opentructures of blasticidin S and leupeptin, two toxins that kill malaria parasites. Both are
ound 2, a speciﬁc PSAC antagonist identiﬁed through a drug discovery project. (C) Dose
ts the best ﬁt to y=1/(1+(x/K0.5)) with a K0.5 of 84 nM. (D) Single channel recordings
d pipette. Dashes next to each trace reﬂect the closed channel level; scale bars beneath
th inhibition by mixtures of compound 2 with blasticidin S or leupeptin (left and right
roduce 50% parasite killing (abscissa and ordinate, respectively) and is the mean of two
teracting drug combinations. Note that the symbols are shifted to the right of this line in
Fig. 2. Propagation of wild-type andmutant parasites without toxins (A), with leupeptin or blasticidin S alone (B and C, respectively), or with both toxins (D). In each panel, symbols
represent % parasitemia determined by daily examination of Giemsa-stained smears after seeding 0.4% ring-stage synchronous cultures. Parasite isolates are distinguished with
different symbols as: FCB (ﬁlled triangles), FCB-br1 (white triangles), FCB-2mut (red triangles), HB3 (ﬁlled circles), HB3-leuR1 (white circles). Notice that cultures of each single
mutant are rapidly killed by the other toxin and that only the double mutant FCB-2mut survives when both toxins are applied.
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quately ﬁtted by the probability density function for a single
exponentially decaying open channel state as described previously
[14], but that of HB3-leuR1 was somewhat more complicated (not
shown). The mean open duration of the wild-type isolates were 0.20–
0.24 ms, matching a previous estimate for channels on the Indo 1
isolate [14]. These similar values suggest conservation of wild-type
channel gating because these three parasites were isolated from
patients in different parts of the world. In contrast, channels induced
by FCB-2mut and HB3-leuR1 exhibitedmarked increases in mean open
durations with measured values of 0.67 ms and 1.46 ms, respectivelyFig. 3. Schematic summarizing the selection of each mutant and requirement for permissive
leupeptin-resistant parasites, but it is incapable of acquiring blasticidin S resistance. (B) FC
(reverse arrow, described below). Although leupeptin resistance can be selected from the
leupeptin resistance directly. The double mutant parasite does not undergo loss of resistance
merozoite progeny because of their slower growth rates (Fig. 2A), suggesting a ﬁtness cost(Pb10−4 in comparisons to corresponding wild-type clones, Mann–
Whitney U test). The distributions of closed durations were more
complex and were not clearly altered in either mutant (right panels in
Fig. 7A and B). As described previously [14], these closed distributions
suggest a minimum of 3 distinct closed states for both wild-type and
mutant channels.
Dwell time distributions were not calculated for the FCB-br1
mutant because the subconductance state present in its recordings
confounded interpretation. We therefore performed power spectral
analyses for all three mutants. As described previously for wild-type
PSAC activity [6], this analysis revealed complex 1/f spectra for eachgenetic backgrounds. (A) HB3 is the only wild-type isolate that has successfully yielded
B can acquire blasticidin S resistance, which is lost upon removal of selective pressure
blasticidin S mutant (FCB-br1), the wild-type FCB parent appears unable to acquire
upon removal of drug pressure. The mutants in panel B are shown as containing fewer
associated with resistance. Leu, leupeptin; blas, blasticidin S.
Fig. 4. Leupeptin accumulation in wild-type and mutant infected cells reveal a pattern
consistent with resistance phenotypes. Leupeptin content of cells infected with
indicated isolates was measured as described in the Materials and methods and is
represented as normalizedmean±S.E.M. of up to 13 independent trials for each isolate.
Wild-type and drug-resistant parasites are shown as grey and black bars, respectively.
Uptake is PSAC-mediated because it is inhibited by 5 µM compound 2 (HB3+2). This
inhibitor also reduced uptake by FCB-infected cells (not shown). Uninfected
erythrocytes lack PSAC activity and exhibit much lower uptake (Uninf). While
blasticidin S resistance confers some reduction in leupeptin uptake (FCB-br1 relative
to FCB, Pb0.001), both leupeptin-resistant mutants exhibit signiﬁcantly lower uptake
(HB3-leuR1 and FCB-2mut, P≤0.001 in comparisons to FCB-br1).
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eachmutant cell line revealed reproducible differences most apparent
at low frequencies (Fig. 7C). These ﬁndings further substantiate the
observed differences in PSAC gating associated with selection of each
mutant phenotype. Complex 1/f spectra are consistent with multiple
kinetic states for this channel as implicated by the closed dwell time
distributions. Fluctuations with this type of spectra have been
reported for several other channels but their mechanisms are still
debated [26,34–37].3.5. Differing abilities of mutants to revert upon removal of selective
pressure
FCB-br1 was previously shown to revert to a wild-type phenotype
when blasticidin S pressure is removed from in vitro cultures [9]. This
reversion process was completed within several weeks and includes
restoration of wild-type sensitivity to killing by blasticidin S, organic
solute permeability, and single channel gating. In contrast, HB3-leuR1
exhibited stable leupeptin resistance and altered PSAC activity despite
removal of leupeptin pressure for 3 months [16]. We therefore
wondered about the stability of the double mutant channel
phenotype when both leupeptin and blasticidin S are removed.
Examination of the phenotype's stability upon removal of drug
pressure is important because it can shed light on the molecular
mechanisms responsible for resistance.
Fig. 8A shows leupeptin accumulation into cells infected by each
mutant before and after drug pressure removal. When blasticidin S
pressure is removed from FCB-br1 cultures, we found that leupeptin
content increased from its intermediate value to wild-type levels
within 4 weeks, providing an independent demonstration of this
mutant's ability to undergo rapid reversion. HB3-leuR1's low leupep-
tin permeability did not revert despite measurements after up to
4 months of in vitro culture without leupeptin pressure. Leupeptinuptake by the FCB-2mut isolate also remained low despite 4 months of
culture without either blasticidin S or leupeptin.
As an independent test, we also examined reversion more
quantitatively by tracking osmotic lysis of cells in isotonic solutions
of phenyltrimethylammonium (PhTMA+), an organic cation with
high PSAC permeability [38]. We selected this solute because it has
relatively well preserved permeability in each mutant (Fig. 8B and C),
permitting accurate estimation of lysis halftime. As found with
leupeptin uptake measurements, these experiments revealed that
FCB-br1 rapidly loses its reduced PhTMA+ permeability upon removal
of drug pressure, but HB3-leuR1 and FCB-2mut do not. Finally, patch-
clamp studies have demonstrated that the altered channel gating on
FCB-br1-infected erythrocytes is lost when the cultures are main-
tained without blasticidin S [9]; our single channel recordings with
HB3-leuR1 and FCB-2mut did not reveal reversion of altered gating
(not shown).
FCB-2mut combines the more marked reduction in PhTMA+
permeability of the blasticidin S single mutant with the greater
reduction in leupeptin permeability seen in the leupeptin single
mutant. Its lack of restored PhTMA+ permeability after removal of
both toxins suggests genome-level changes required for addition of
leupeptin resistance stabilize the changes selected by blasticidin S.
Consistent with these stable changes in transport properties, FCB-
2mut cultures exhibited unchanged growth rates when challenged
with both leupeptin and blasticidin S after culturing for 4 months
without these toxins (not shown).
4. Discussion
Mutant selection in microbes, as used in the present study, is an
important research tool in the study of cellular biology and
biochemistry. The primary advantage of single-celled microbes over
higher organisms for such studies is the large number of independent
wild-type cells that can be screened for desired mutations. Classical
studies in viruses, bacteria and yeasts have identiﬁed countless
mutants under stringent selective conditions [39,40]. A number of
mutant selections have also been carried out in P. falciparum [41–43],
despite this organism's signiﬁcantly slower replication rate and more
restrictive growth requirements.
How might leupeptin and blasticidin S select for altered PSAC
activity? Because the genetic basis of this activity is presently
unknown, we consider several possibilities. First, channel activity
may reﬂect one or more parasite-encoded proteins trafﬁcked to the
host membrane. In this scenario, the toxins could select for mutations
in the responsible parasite genes to yield channels that produce
reduced toxin uptake by altering key residue(s) involved in solute
permeation. Second, the channel may be endogenous to the host
membrane, but may require activation by one or more parasite-
encoded enzymes [44,45]. Here, mutations in these enzymes may be
selected by the toxins to alter activation, yielding modiﬁed channels
that limit toxin uptake. Third, the channel may consist of both host-
and parasite-encoded proteins such that mutations in the parasite
component can lead to altered channel activity. Fourth, it is possible
that toxin exposure affects parasite metabolism and leads to
production of soluble modulators that alter channel activity [46].
This scenario would require that some of these changes inmetabolism
be irreversible because channels on HB3-leuR1 and FCB-2mut do not
revert to wild-type channels despite removal of toxin for many
generations. Although functional polymorphisms between geograph-
ically divergent parasites not subjected to selection with toxins
suggest at least one parasite-encoded channel subunit [8,10],
deﬁnitively distinguishing between these possibilities will require
identiﬁcation of the channel's gene(s).
Because some studies have suggested multiple distinct ion
channels on the infected erythrocyte membrane [7], we wondered
whether leupeptin and blasticidin S might be selecting for changes in
Fig. 5. Single channel recordings on erythrocytes infected with eachwild-type ormutant parasite, as indicated. (A) Black scale bars beneath traces represent 100 ms (horizontal) and
3 pA (vertical). (B) For each parasite, the three traces shown reﬂect recordings from three separate cells. Scale bars represent 10 ms and 3 pA for all traces in this panel. Red and green
dashes ﬂanking each trace represent the closed and open channel states, respectively. FCB-br1 channels also exhibit an intermediate conductance level [9]. Notice that each isolate's
characteristic channel gating behavior is reproducible and distinct.
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effects on a single ion channel type. First, we tallied our experience
with cell-attached patch-clamp of the isolates presented here. A total
of 317 patches with seal resistanceN50 GΩ were examined from the
two wild-type isolates and compared to patches from the three
mutants (n between 77 and 196 patches for each mutant). Overall,
26% of patches yielded one or more channels. Although there was
some molecule-to-molecule variation, we never detected the charac-
teristic gating behavior of any of the three mutant lines on cells
infected with either wild-type parasite; instead, gating behavior was
highly reproducible and distinct between the ﬁve cloned parasites we
examined (Fig. 5), suggesting that both toxins select for changes in asingle channel type. Second, although there were signiﬁcant differ-
ences in open channel dwell distributions, the closed channel
distributions were essentially identical on our parasite lines and
quite different from other well-characterized ion channels. Conser-
vation of closed durations along with similar single channel
conductances on these isolates also suggests relatively modest
changes in a single channel type. Finally, two distinct PSAC inhibitors
have parallel effects on parasite killing by these two toxins (Fig. 1E;
[16]), suggesting a single shared uptake mechanism. The similar
properties of the channels detected (closed channel durations, 1/f
power spectra, single channel conductance, and pharmacology)
combined with the failure to detect mutant channel behavior on
Fig. 6. Chord conductances for channels detected on indicated parasites. Conductances
were calculated from cell-attached recordings at −100 mV relative to the holding
potential of 0 mV. n=12–22 channel molecules for each parasite.
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tions of a single ion channel type in the selection of resistance to one
or both antimalarial toxins. Nevertheless, we cannot exclude
contributions of unrelated channels that might have escaped
detection by our study.Fig. 7. Dwell time distributions reveal signiﬁcantly differing gating properties for the mutant
respectively). (B) Comparison of gating properties of channels from HB3 and HB3-leuR1 (b
points binning of tallied durations from up to 104,000 channel events. In both (A) and (B
respectively. (C) Power spectra of single channel recordings from HB3-leuR1 (green traces
reﬂect analyses from three separate channel molecules. The clustering of each group indic
selection of FCB-2mut from the FCB-br1 background produces marked changes in channel pr
permit comparison to the slope of each mutant channel's power spectrum.Solutes that share a single ion channel may compete for binding
sites within the pore and reduce each other's ﬂux. We examined this
possibility and found no detectable slowing of sorbitol uptake in
osmotic lysis experiments by either 5 µM blasticidin S or 50 µM
leupeptin. We also performed single channel patch-clamp in the
presence of 100 µM leupeptin and did not see signiﬁcant changes in
PSAC conductance or dwell time distributions (data not shown). This
lack of effect is consistent with the poor saturability of this channel
[6,8]. Indeed, competition between permeating solutes is a complex
function of channel and solute geometries, the strength of solute
interactions within the pore, and solute diffusion coefﬁcients, which
may vary along the length of the channel pore [47]. Thus, competition
between solutes in a pore frequently escapes detection.
Only certain laboratory parasite isolates appear capable of accruing
the changes required for resistance to leupeptin or blasticidin S
(Fig. 3), suggesting DNA-level polymorphisms in one or more parasite
genes that are permissive for selection of resistance. Despite multiple
attempts with other parasite isolates, we successfully generated
channel-mediated blasticidin S resistance in only the FCB laboratory
isolate. This may account for the successful use of this toxin in parasite
DNA transfection experiments that select for plasmid-encoded
blasticidin S deaminase (BSD): most of those studies utilized other
parasite isolates [17,19,20]. Continued, cautious use of this reagent
seems appropriate, especially because there are only a few selectable
markers available in this system. Acquired leupeptin resistance via
reduced channel-mediated permeability also required use ofs. (A) Comparison of PSAC gating properties for FCB and FCB-2mut (black and red traces,
lack and red traces, respectively). Each histogram in these 4 panels corresponds to all
), the left and right panels show distributions of open and closed channel durations,
), FCB-br1 (black traces), and FCB-2mut (red traces). For each mutant, the three traces
ates reproducible differences between these mutant channels. Notice especially, that
operties. The dashed black line is an arbitrary line with a slope of 1/f and is included to
Fig. 8. Differing capacities of mutants to revert to wild-type phenotype upon removal of
selective pressure. (A) Normalized leupeptin accumulation into cells infected with
indicated isolates. In this and subsequent panels, uptake is shown into mutant infected
cells obtained from cultures under continuous selective pressure or after extended
propagation without either toxin (+ and −, respectively). Notice that FCB-br1
undergoes reversion to a level matching its wild-type parent (FCB) after removal of
selective pressure, but that the other twomutants exhibit stable reductions. (B) Osmotic
lysis kinetics of cells infected with indicated isolates in PhTMA+ chloride. For each cell
type, PhTMA+ uptake is the rate-limiting determinant of lysis kinetics. Notice faster
kinetics of lysis upon blasticidin S removal for FCB-br1, but sustained slow PhTMA+
uptake in FCB-2mut after culturing without either toxin. (C) Mean±S.E.M. osmotic lysis
halftimes determined from kinetic experiments as in (B). The measured halftime is
inversely proportional to PhTMA+ permeability [24]. While reversion from a resistant
phenotype is apparent as an increase in leupeptin uptake in (A), it is reﬂected by a
decrease in lysis halftime in (C).
1687G. Lisk et al. / Biochimica et Biophysica Acta 1798 (2010) 1679–1688permissive parasite isolates in our hands (HB3 and FCB-br1, but not
FCB). Identiﬁcation of the channel's gene(s) may help reveal the
molecular basis of these isolate-speciﬁc differences.
We noticed that the concentrations of leupeptin and blasticidin S
required to kill parasite cultures are signiﬁcantly higher than those
required to inhibit their intracellular targets. For example, leupeptin
inhibits falcipains, a family of proteases in the parasite's digestivevacuole, with low nanomolar afﬁnity [48], but parasite growth
inhibition is not seen until ∼104-fold higher extracellular concentra-
tions are applied. Blasticidin S also appears to inhibit protein synthesis
by cellular extracts with ∼10-fold greater afﬁnity than one might
predict from in vitro parasite killing [49]. These discrepancies are
consistent with our studies that suggest toxin uptake at the
erythrocyte membrane is rate-limiting. It is also consistent with
pore sieving considerations that predict relatively low permeability
for these large toxin molecules. Modest reductions in toxin perme-
ability, such as we have selected, should be sufﬁcient to confer in vitro
resistance to killing.
While our single channel recordings reveal a correlation between
gating and toxin resistance phenotypes, it is important to recognize
that altered gating behavior does not directly contribute to acquired
resistance. Instead, changes in channel solute selectivity that reduce
toxin uptake (Fig. 4) are more likely to be directly responsible for
toxin resistance; altered gating appears to be a byproduct and is
fortuitous for our patch-clamp studies. This model is consistent with
channel mutants in other systems, where relatively modest changes
in sequence or structure can often have multiple effects on single
channel properties [50,51]. We speculate that residues on the PSAC
protein critical for determining the channel's solute selectivity overlap
or interact with those involved in gating.
Our study highlights PSAC's remarkable ability to distinguish
between structurally similar solutes despite a broad spectrum of
solutes that can be transported. Leupeptin and blasticidin S are both
linear hydrocarbon compounds, carry a charged guanidinium moiety,
and have almost identical molecular weights; nevertheless, they can
still be distinguished within the PSAC pore, as evidenced by their
abilities to select for distinct in vitro resistance phenotypes and
channel activities. Other studies have also pointed to unusual
selectivity mechanisms in this channel. For example, the small Na+
ion is stringently excluded from permeation in spite of the broad
permeability of larger organic cations [13]. Additional examples
include the channel's ability to pass some amino acids and sugars
while excluding others [52] and to transport proline and hydroxy-
proline by distinct mechanisms [53]. While several other channels can
also distinguish similar solutes [54,55], PSAC appears to be relatively
unique in its ability to pass a diverse collection of solutes that cannot
be precisely deﬁned based on net charge, molecular weight,
hydrophobicity, or other simple criteria. Our study extends the
understanding of PSAC's selectivity ﬁlter by identifying mutants
capable of ﬁne-tuning the list of permeant solutes. How permeating
solutes interact with the channel pore is presently unknown, but we
propose that there may be multiple contact points that can be
individually tweaked to produce changes in relative permeabilities of
structurally similar solutes.
Our study also has important implications for antimalarial drug
discovery programs targeting intraerythrocytic parasite activities.
Water-soluble drug leads that are bulky or chargedmay require PSAC-
mediated uptake to enter the erythrocyte and reach their targets. This
requirement can be conﬁrmed through straightforward examination
of the lead compound's in vitro growth inhibitory efﬁcacy in the
presence of a known PSAC inhibitor (Fig. 1E); we suggest that such
testing be incorporated into all antimalarial drug discovery and
development programs. If decreased growth inhibitory effectiveness
of an antimalarial drug lead is seen when PSAC inhibitors are added,
there is a real concern that parasites may acquire resistance via the
drug resistance mechanism described here.Acknowledgements
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